Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Exemestane, sold under the brand name Aromasin among others, is a medication used to treat breast cancer. It is a member of the class of antiestrogens known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive. They may also be called estrogen-responsive…
Community, Culture, Applications & Research
Explore the main themes, entities and connections around Exemestane. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
estrogen aromatase breast women cancer also postmenopausal tamoxifen enzyme inhibitors therapy cancers cyp3a4 inhibitor aromasin adjuvant premenopausal treatment patients mg
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Exemestane | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Exemestane | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Exemestane | ATC code | L02BG06 (WHO) | 1.00 | infobox |
| Exemestane | Bioavailability | ~60%[citation needed] | 1.00 | infobox |
| Exemestane | CAS Number | 107868-30-4 Y | 1.00 | infobox |
| Exemestane | ChEBI | CHEBI:4953 N | 1.00 | infobox |
| Exemestane | ChEMBL | ChEMBL1200374 Y | 1.00 | infobox |
| Exemestane | ChemSpider | 54278 Y | 1.00 | infobox |
| Exemestane | CompTox Dashboard (EPA) | DTXSID5023037 | 1.00 | infobox |
| Exemestane | Drug class | Aromatase inhibitor; Antiestrogen | 1.00 | infobox |
| Exemestane | DrugBank | DB00990 Y | 1.00 | infobox |
| Exemestane | Duration of action | 4–5 days[citation needed] | 1.00 | infobox |
| Exemestane | ECHA InfoCard | 100.171.149 | 1.00 | infobox |
| Exemestane | Elimination half-life | 24 hours | 1.00 | infobox |
| Exemestane | Excretion | Urine and feces ~ 1:1 (mainly metabolites) | 1.00 | infobox |
| Exemestane | Formula | C20H24O2 | 1.00 | infobox |
| Exemestane | IUPHAR/BPS | 7073 | 1.00 | infobox |
| Exemestane | KEGG | D00963 Y | 1.00 | infobox |
| Exemestane | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Exemestane | Legal status | US: ℞-only | 1.00 | infobox |
| Exemestane | MedlinePlus | a607006 | 1.00 | infobox |
| Exemestane | Metabolism | Liver (CYP3A4, aldo-keto reductase) | 1.00 | infobox |
| Exemestane | Molar mass | 296.410 g·mol−1 | 1.00 | infobox |
| Exemestane | Other names | FCE-24304 | 1.00 | infobox |
| Exemestane | Pronunciation | /ˌɛksəˈmɛˌsteɪn/ EK-sə-ME-stayn | 1.00 | infobox |
| Exemestane | Protein binding | 90% | 1.00 | infobox |
| Exemestane | PubChem CID | 60198 | 1.00 | infobox |
| Exemestane | Routes of administration | By mouth | 1.00 | infobox |
| Exemestane | Trade names | Aromasin | 1.00 | infobox |
| Exemestane | UNII | NY22HMQ4BX | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.